Loading patent…
AssigneesChung Ang University Industry Academic Cooperation Foundation, Haplnscience Inc.
InventorsDae Kyong Kim, Yong Soon Kim, Moon Jung Back, Jung Hoon Pyo, David Kim, Yong Wei Piao, Min A Yeom
Estimating the term…
Disclosed in the present invention are: a pharmaceutical composition for preventing or treating fibrotic diseases, comprising hyaluronan and proteoglycan link protein 1 (HAPLN1) or a gene encoding same as an active ingredient; and a method for preventing or treating fibrotic diseases using the composition. According to the present invention, fibrosis of cells or tissues is prevented and inhibited such that the occurrence or progression of various kinds of diseases caused by fibrosis is fundamentally suppressed, and thus the diseases can be prevented or treated.
A method of treating a fibrotic disease of a subject, comprising selecting the subject with a fibrotic disease, and administering or applying a therapeutically effective amount of hyaluronan and proteoglycan link protein 1 (HAPLN1) protein or a gene encoding the same as an active ingredient to the subject.
A method of inhibiting fibrosis of a cell by treating the cell with a composition comprising HAPLN1 protein or a gene encoding the same as an active ingredient.
(canceled)
Dependencies are inferred from the claim text.